Kopczak Anna, Krewer Carmen, Schneider Manfred, Kreitschmann-Andermahr Ilonka, Schneider Harald Jörn, Stalla Günter Karl
Clinical Neuroendocrinology Group, Max Planck Institute of Psychiatry, Kraepelinstraße 2-10, Munich 80804, Germany.
Schön Klinik Bad Aibling, Kolbermoorer Straße 72, Bad Aibling 83043, Germany.
Int J Mol Sci. 2015 Dec 22;17(1):2. doi: 10.3390/ijms17010002.
Previous reports suggest that neuroendocrine disturbances in patients with traumatic brain injury (TBI) or aneurysmal subarachnoid hemorrhage (SAH) may still develop or resolve months or even years after the trauma. We investigated a cohort of n = 168 patients (81 patients after TBI and 87 patients after SAH) in whom hormone levels had been determined at various time points to assess the course and pattern of hormonal insufficiencies. Data were analyzed using three different criteria: (1) patients with lowered basal laboratory values; (2) patients with lowered basal laboratory values or the need for hormone replacement therapy; (3) diagnosis of the treating physician. The first hormonal assessment after a median time of three months after the injury showed lowered hormone laboratory test results in 35% of cases. Lowered testosterone (23.1% of male patients), lowered estradiol (14.3% of female patients) and lowered insulin-like growth factor I (IGF-I) values (12.1%) were most common. Using Criterion 2, a higher prevalence rate of 55.6% of cases was determined, which correlated well with the prevalence rate of 54% of cases using the physicians' diagnosis as the criterion. Intraindividual changes (new onset insufficiency or recovery) were predominantly observed for the somatotropic axis (12.5%), the gonadotropic axis in women (11.1%) and the corticotropic axis (10.6%). Patients after TBI showed more often lowered IGF-I values at first testing, but normal values at follow-up (p < 0.0004). In general, most patients remained stable. Stable hormone results at follow-up were obtained in 78% (free thyroxine (fT4) values) to 94.6% (prolactin values).
先前的报告表明,创伤性脑损伤(TBI)或动脉瘤性蛛网膜下腔出血(SAH)患者的神经内分泌紊乱可能在创伤后数月甚至数年仍会出现或缓解。我们调查了一组n = 168例患者(81例TBI后患者和87例SAH后患者),在这些患者的不同时间点测定了激素水平,以评估激素不足的病程和模式。使用三种不同标准分析数据:(1)基础实验室值降低的患者;(2)基础实验室值降低或需要激素替代治疗的患者;(3)主治医生的诊断。受伤后中位时间三个月后的首次激素评估显示,35%的病例激素实验室检查结果降低。睾酮降低(男性患者的23.1%)、雌二醇降低(女性患者的14.3%)和胰岛素样生长因子I(IGF-I)值降低(12.1%)最为常见。使用标准2,确定的患病率较高,为55.6%,这与以医生诊断为标准的54%的患病率密切相关。个体内变化(新发不足或恢复)主要见于生长激素轴(12.5%)、女性促性腺激素轴(11.1%)和促肾上腺皮质激素轴(10.6%)。TBI后患者在首次检测时IGF-I值更常降低,但随访时为正常值(p < 0.0004)。总体而言,大多数患者保持稳定。随访时激素结果稳定的比例为78%(游离甲状腺素(fT4)值)至94.6%(催乳素值)。